SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 80 filers reported holding SAVARA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $51,729 | -35.5% | 12,836 | -20.2% | 0.00% | – |
| Q1 2024 | $80,148 | +38.5% | 16,094 | +30.7% | 0.00% | – |
| Q4 2023 | $57,876 | +80283.3% | 12,314 | -73.6% | 0.00% | – |
| Q4 2022 | $72 | -99.9% | 46,700 | 0.0% | 0.00% | – |
| Q3 2022 | $72,000 | -64.5% | 46,700 | -60.9% | 0.00% | -100.0% |
| Q2 2021 | $203,000 | -2.9% | 119,489 | +19.1% | 0.00% | 0.0% |
| Q1 2021 | $209,000 | -23.4% | 100,345 | -8.4% | 0.00% | -66.7% |
| Q2 2020 | $273,000 | +17.7% | 109,537 | +0.2% | 0.00% | 0.0% |
| Q1 2020 | $232,000 | +14.9% | 109,317 | +142.3% | 0.00% | +50.0% |
| Q4 2019 | $202,000 | +281.1% | 45,122 | +101.4% | 0.00% | +100.0% |
| Q2 2019 | $53,000 | -53.5% | 22,400 | +44.5% | 0.00% | -50.0% |
| Q1 2019 | $114,000 | -2.6% | 15,500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $117,000 | – | 15,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 4,980,804 | $16,026,005 | 46.25% |
| NEA Management Company, LLC | 24,137,931 | $77,120,690 | 5.89% |
| Bain Capital Life Sciences Investors, LLC | 11,622,598 | $37,134,201 | 3.82% |
| VR Adviser, LLC | 6,351,531 | $20,293,142 | 3.24% |
| Sio Capital Management, LLC | 1,010,701 | $3,229,190 | 0.82% |
| ACUTA CAPITAL PARTNERS, LLC | 198,139 | $633,054 | 0.43% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,908,086 | $34,851,335 | 0.18% |
| Parkman Healthcare Partners LLC | 206,607 | $660,109 | 0.11% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,064,551 | $19,376,240 | 0.04% |
| ClariVest Asset Management LLC | 242,900 | $776 | 0.04% |